Back to Search
Start Over
The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis
- Source :
- Photochemical & Photobiological Sciences. 1:158-168
- Publication Year :
- 2002
- Publisher :
- Springer Science and Business Media LLC, 2002.
-
Abstract
- Photodynamic therapy (PDT) is a treatment for cancer and pre-malignant conditions, which involves the administration of a photosensitising agent followed by exposure of the tissue to light. 5-Aminolaevulinic acid (ALA) is a naturally occurring compound in the haem biosynthetic pathway, which is metabolised to a photosensitive product, protoporphyrin IX (PpIX). The major advantage of ALA when compared to synthetic photosensitisers is the rapid metabolism, which significantly reduces the period of cutaneous photosensitivity. This review focuses on the development of ALA as a photosensitiser in photodynamic therapy and photodiagnosis, and the wide range of clinical applications in which ALA is now being used as a therapeutic modality.
- Subjects :
- Photosensitizing Agents
Protoporphyrin IX
medicine.medical_treatment
Photodynamic therapy
Aminolevulinic Acid
Pharmacology
chemistry.chemical_compound
Photochemotherapy
chemistry
Biochemistry
Neoplasms diagnosis
Neoplasms
medicine
Humans
Cutaneous photosensitivity
Physical and Theoretical Chemistry
5 aminolaevulinic acid
Subjects
Details
- ISSN :
- 14749092 and 1474905X
- Volume :
- 1
- Database :
- OpenAIRE
- Journal :
- Photochemical & Photobiological Sciences
- Accession number :
- edsair.doi.dedup.....bdd4096c699c098a7ccc4d9a7a77f494